MTNB
Matinas Biopharma Holdings Inc

11,217
Mkt Cap
$8.14M
Volume
0.00
52W High
$3.35
52W Low
$0.4748
PE Ratio
-0.41
MTNB Fundamentals
50D MA
$1.82
Beta
1.52
Avg. Volume
62,336.90
EPS (Annual)
-$4.98
P/B
1.06
Rev/Employee
$0.00
Loading...
Loading...
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7

Frequently Asked Questions

What is Market Cap of Matinas Biopharma Holdings Inc?
What is the 52-week high for Matinas Biopharma Holdings Inc?
What is the 52-week low for Matinas Biopharma Holdings Inc?
What is the PE ratio of Matinas Biopharma Holdings Inc?
What is the Price-to-Book ratio of Matinas Biopharma Holdings Inc?
What is the 50-day moving average of Matinas Biopharma Holdings Inc?
How many employess does Matinas Biopharma Holdings Inc has?

Latest MTNB News

View
No MTNB news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.